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Abstract Pro-apoptotic Bax is a soluble and monomeric
protein under normal physiological conditions. Upon its
activation substantial structural rearrangements occur: The
protein inserts into the mitochondrial outer membrane and
forms higher molecular weight oligomers. Subsequently,
the cells can undergo apoptosis. In our studies, we focused
on the structural rearrangements of Bax during oligomeri-
zation and on the protein stability. Both protein conforma-
tions exhibit high stability against thermal denaturation,
chemically induced unfolding and proteolytic processing.
The oligomeric protein is stable up to 90 °C as well as in
solutions of 8 M urea or 6 M guanidinium hydrochloride.
Helix 9 appears accessible in the monomer but hidden in
the oligomer assessed by proteolysis. Tryptophan fluores-
cence indicates that the environment of the C-terminal
protein half becomes more apolar upon oligomerization,
whereas the loop region between helices 1 and 2 gets
solvent exposed.
Keywords Bcl-2 proteins.Apoptosis.
Conformationalchanges.Proteinstructure.Proteinstability
Abbreviations
aa amino acid
CD circular dichroism
CHAPS cholamidopropyldimethylammonio-
propansulfonat
DDM dodecylmaltoside
DM decylmaltoside
DO dioleyl;
ER endoplasmatic reticulum
NMR nuclear magnetic resonance
OG octyl-glucoside
MOM mitochondrial outer membrane
PC phosphatidylcholine
PE phosphatidylethanolamine
PI phosphatidy-linositol
PS phostphaidylserine
SEC size exclusion chromatography
TF tryptophan fluorescence
Introduction
In order to maintain the survival of complex organisms,
cells need a strict regulation of division and cell death
programs. Members of the Bcl-2 protein family are
essential factors in this regulation (Cory and Adams 2002;
Kuwana and Newmeyer 2003). The Bcl-2 proteins can be
divided into three subgroups: First the anti-apoptotic Bcl-2
like proteins, second the pro-apoptotic multi-domain pro-
teins, and third the pro-apoptotic BH3 only proteins.
Human Bax alpha (abbreviated Bax) is probably the best
studied example within this family and belongs to the pro-
apoptotic multi-domain proteins. Moreover, Bax is one of
the key factors known to initiate apoptosis in vertebrates.
Deletion of Bax and its homolog Bak in mice leads to
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Monomeric Bax protein is cytosolic and inactive. Upon
activation, it can undergo a conformational change to form
an oligomeric protein complex that inserts into the MOM
(Antonsson et al. 2001; Youle and Karbowski 2005). By
this, Bax permeabilizes the membrane for cytochrome c
(Kuwana et al. 2002) and downstream apoptotic events can
be initiated. The conformational change of Bax is regulated
by an ever growing number of proteins [e.g. Bid and Bim
(Chipuk et al. 2006; Kuwana et al. 2005; Lovell et al.
2008), Bif1 (Cuddeback et al. 2001; Takahashi et al. 2005),
p53 (Chipuk et al. 2004; Mihara et al. 2003), ASC
(Ohtsuka et al. 2004), Ku70 (Sawada et al. 2003), 14-3-3
(Nomura et al. 2003) or Humanin (Guo et al. 2003)]. In
vitro, activation and oligomerization can be induced by
mixing Bax with detergents (Antonsson et al. 2000;
Antonsson et al. 2001; Hsu and Youle 1997, 1998; Kuwana
et al. 2002; Suzuki et al. 2000). Obviously, in living cells
Bax activation has to be strictly regulated since premature
activation may leads to sudden cell death while blocked
activation favors early cancer development.
The structure of monomeric Bax has been determined by
NMR methods (Suzuki et al. 2000) and shows a globular
fold composed of nine alpha helices, termed α1t oα9. In
the structure, α5 is hidden in the hydrophobic core and α9
is attached to a hydrophobic cleft on the protein surface. In
contrast, the structure of oligomeric Bax is unknown, but it
was demonstrated by biochemical methods that α5, α6 and
α9 may be inserted into the OMM (Annis et al. 2005;
Garcia-Saez et al. 2004; Nechushtan et al. 1999; Wolter et
al. 1997).
The aim of this work was to study the conforma-
tional changes upon Bax oligomerization in order to
understand the underlying architecture of the oligomeric
complex. In our study, we compared monomeric and
oligomeric Bax (in detergents or reconstituted in lip-
osomes) using CD-spectroscopy, tryptophan fluorescence
(TF), protease digestion, size exclusion chromatography
(SEC) and chemical cross-linking. Our results indicate
that Bax is extraordinarly stable in the oligomeric form.
During monomer to oligomer transition the protein
undergoes the following conformational changes: (a)
helix α9 becomes protected against protease attack
whereas (b) α1 moves in a protease accessible position.
(c) The tryptophans in α5t oα9e x p e r i e n c eam o r e
hydrophobic environment. (d) The monomer shows an
unusually high energy barrier for unfolding but needs a
hydrophobic environment to adopt the active conforma-
tion. (e) The oligomerization even further stabilizes the
protein against unfolding. (f) In the complex, the protein
is tightly packed and protected towards thermal and
chemical stress.
Material and methods
ClustalW alignment In order to perform the alignment,
amino acid sequences from different vertebrate species
annotated as Bax isoform alpha [human (Q07812), rat
(Q63690), mouse (Q07813), bovine (O022703)] or com-
plete sequences having an equivalent start codon assign-
ment [cat (Q8SQ43), dog (Q8HYUS), zebra fish (Q919N4)]
as well as having only a short extension [xenopus
(Q98U13)] were used. Sequences with N-terminal exten-
sions or deletions within the sequence were excluded, e.g.
the sequence from Pan troglodytes (chimpanzee), which
shows only two differences in the part homologous to the
human Bax alpha, but is elongated by 70 amino acids at the
N-terminus.
Expression and purification of human Bax alpha We
essentially followed the procedure described by Suzuki et
al. (2000). The purity of the protein was analyzed by SDS-
PAGE and LC-MS (calculated mass: 21,184 Da; determined
mass: 21,183 Da).
Bax reconstitution in liposomes Lipid mixtures from E. coli
or bovine heart extracts (Avanti polar lipids Inc. Alabaster,
AL) were dissolved in chloroform, dried by evaporation to
form a thin film, and resuspended in buffer 1 (20 mM Tris–
HCl, 100 mM NaCl; pH 7.5) by repeatedly vortexing,
freezing and thawing. The final lipid concentration was
20 mg/ml. The solution was passed through a membrane
with 200 or 400 nm pores (Avestin Inc. Ottawa, Canada) for
at least 25 times. Bax pre-incubated with 0.1% DDM was
mixed with the vesicles pre-incubated with 0.1% DDM to a
final concentration of 0.25 mg/ml protein and 12 mg/ml
lipid. Biobeads (BioRAD, Hercules, CA) were added to
remove excess detergent. For protein insertion the solution
was incubated for 3 h at 30 °C at 300 rpm. To remove free
protein as well as aggregates, a nycodenz gradient was used.
The gradient was layered as followed: the liposome/Bax
solution in 10% nycodenz (dissolved in buffer 1) was
overlaid with 5% nycodenz in buffer 1 and finally pure
buffer 1. The gradient was spun at 200,000×g for 30 min at
10 °C. A pellet and a swimming lipid band (fuzzy when
bovine heart lipids were used) were separated. The latter was
mixed with buffer 1 and centrifuged under identical
conditions to remove the nycodenz by sedimentation.
Secondary structure determination by circular-dichroism
spectroscopy The concentration of Bax (in buffer 2; 20 mM
Tris, pH 8.8) was adjusted to 0.1 mg/ml. The CD-spectra
and melting curves were recorded on a Jasco J715
spectropolarimeter (Jasco, Gross Umstadt, Germany) with
a Jasco PFD 350S Peltier type FDCD attachment for
temperature control using a 0.1 mm quartz cuvette. Two
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pitch of 0.1 nm, a scan speed of 20 nm s
−1 and 1 nm slit
width. The content of secondary structure was calculated
using the program CDNN (Bohm et al. 1992). Notably,
samples of Bax did not show any precipitation during the
temperature increase which was tested by UV-spectroscopy.
If buffer 1 was used instead of buffer 2, only neglectable
differences were visible in the spectra.
Protease digestion Monomeric and oligomeric Bax sam-
ples were mixed with subtilisin or proteinase K at a
stoichiometry of 1:200 and incubated for one hour on ice.
The reaction was stopped either by (a) treatment with the
denaturing SDS-gel loading buffer and subsequent boiling
for 5 min or (b) freezing in liquid nitrogen and storage at
−80 °C before further analysis. Protein samples were
subjected to SDS-PAGE and blotted onto a PVDF
membrane (transfer buffer: 25 mM Tris–HCl, 192 mM
glycine, 20% methanol) for subsequent N-terminal se-
quencing of individual bands (using a gas-phase sequencer
Procise 492cLC, Applied Biosystems, Foster City, CA).
Sample mixtures were also analyzed by ESI-MS. After Bax
reconstitution in liposomes, the protein concentration was
estimated by the band intensity on a SDS-gel. Consequent-
ly, the estimation was less accurate than the estimation by
UV spectroscopy. Furthermore, since ESI-MS did not work
with Bax liposomes only N-terminal sequencing was
performed.
Tryptophan fluorescence Fluorescence emission spectra
were recorded on a Perkin-Elmer spectrometer (LS50B,
Waltham MA). Bax (concentrations of 0.25 to 1 μM),
and free acetylated-tryptophan (4 μM) were excited at
280 nm at a slit width of 5 nm to detect the emitted
fluorescence in the range between 300 and 400 nm.
Cross-link experiments Protein samples were adjusted to a
concentration of about 0.5 mg/ml in the presence or
absence of 0.5% DDM. These samples were slowly heated
to 50–90 °C and the temperature was kept constant for
600 s. Afterwards, the samples were immediately cooled on
ice. 10 μl samples were mixed with 1 μl ammonium
peroxydisulfate (APS, 25 mM) and 2 μl ruthenium (II)
Tris–bipyridyldication (5 mM Sigma-Aldrich) in the dark
and then immediately exposed to illumination with visible
light (400 to 700 nm, generated by a Xenon lamp, 100 W
Leica, filters: KG4, GG 395 nm). The photo-induced
reaction was stopped by the addition of 5 μl SDS-gel
loading buffer.
Miscellaneous To induce oligomerization, Bax was mixed
with 0.5% DM (Anatrace), 0.5% DDM (Anatrace) or 2%
OG (Anatrace) in buffer 1. The samples were incubated
under shaking for at least 8 h at 4 °C. The oligomerization
was analyzed by size exclusion chromatography on a
Superdex 200 column using SMART FPLC (GE Health-
care). ESI-MS was performed on a micrOTOF LC (Bruker
Daltonics, Billerica, MA). Absorption spectra were collect-
ed on a Shimadzu UV-1700 UV-visible spectrophotometer.
Bax structure was illustrated with Pymol using the PDB file
1F16 of monomeric Bax (Suzuki et al. 2000). Data were
plotted using origin 6.1.
Results
Primary structure analysis of Bax
Bax alpha is a 21 kDa splice variant of human Bax that
is composed of 192 amino acids. The protein contains
three of four known Bcl-2 homology domains, BH1-3
(Fig. 1a), and the NMR structure (Suzuki et al. 2000)
revealed nine alpha helices, α1–α9( F i g .1a, b). While
studies on Bax proteins from other sources are rare,
human Bax has been extensively described in the
literature. In order to locate conserved residues which
may be relevant for the conformational change or
oligomer formation, the Bax protein was aligned with
Bax orthologs from different mammalian and vertebrate
origin (see Fig. 2). The overall similarity of the mamma-
lian orthologs was too high (91% identity; see Fig. 2)t o
identify conserved residues relevant for protein function.
However, after alignment of human Bax alpha with
sequences from the vertebrate species Xenopus laevis
and Danio rerio (see Fig. 2) less conserved sequence
sections became apparent. The overall sequence homol-
ogy dropped to 76% and only 44% of the amino acid
residues were identical. The C-terminal part including
the entire structural parts supposedly involved in the
activation process starting at the BH1 domain (α5–α9,
amino acids 98 to 192 in Bax) is significantly higher
conserved (90% homology) than the N-terminal part of
the protein (62% homology). The conserved amino
acids were highlighted in the NMR-structure model of
monomeric human Bax alpha (shown in Fig. 1c). A
surface exposed domain and the protein core were shown
to be most conserved among Bax from different species.
The invariant surface region is formed by amino acids of
α2, the loop between α4a n dα5, part of α5a sw e l la st h e
region of α7t oα9. In other words, all three Bcl-2
homology domains are involved (see Fig. 1a–c). In
addition, the conserved surface region is surprisingly
hydrophobic (as indicated by the green hue in Fig. 1d),
which might indicate a specific role in membrane
interaction or oligomerization.
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oligomeric Bax For the structural comparison of monomer-
ic and oligomeric Bax, the protein was expressed in
Escherichia coli and purified in its monomeric form as
specified in (Suzuki et al. 2000) (see Fig. 3a). According to
previous studies (Antonsson et al. 2000; Antonsson et al.
2001; Kuwana et al. 2002), the purified protein was mixed
with detergents such as OG, DM and DDM to induce
oligomerization. In order to investigate the influence of the
individual detergents more thoroughly, we used detergents
of various alkyl chain lengths (8, 10 and 12) as well as
different head group moieties.
The secondary structures of Bax in the monomeric and
oligomeric forms were compared by CD spectroscopy
(Fig. 3b). Only minor structure differences were induced
upon detergent-induced oligomerization. Monomeric and
oligomeric Bax in 0.5% DDM showed the typical CD
spectrum of a purely α-helical protein (maximum at
192 nm, minima at 208 nm and 222 nm, shown in
Fig. 3b). Oligomerization of Bax in 0.5% DM or 2% OG
showed comparable results (data not shown). The α-helical
content was determined to be about 60% for the monomer
and about 64% for the oligomer. This is in close agreement
with previously published CD spectra of monomeric human
Bax alpha that displayed approximately 66% α-helix
content (Yethon et al. 2003). As well, the NMR structure
of monomeric Bax shows that 65% of the amino acids are
contained in helices (Suzuki et al. 2000). From these data,
we concluded that Bax was properly folded in the
monomeric and the oligomeric form and only a small
portion of the secondary structure was restructured upon
detergent-induced oligomerization. The oligomerization of
Bax in detergents was later confirmed by SEC (see Fig. 3c).
Bax reconstituted in liposomes was not analyzed by CD
due to insufficiently accurate protein concentration deter-
mination (see Material and Methods).
The C-terminal domain of Bax is in close contact to the
hydrophobic detergent environment after oligomerization As
outlined above, the sequence comparison of Bax orthologs
showed a significantly higher conservation of the C-
terminal part of the protein (see Fig. 2). All six tryptophans
Fig. 1 Representation of conserved regions, and hydrophobicity in
the Bax structure. The secondary as well as a cartoon of the ternary
structure of Bax (PDB:1F16) are shown in a and b, respectively.
Helices are colored according to the code: α1 yellow, α2 fawn, α3
orange, α4 pink, α5 light red, α6 dark red, α7 purple, α8 blue, α9
green. c Shows a representation of the sequence conservation of the
Bax surface. Conserved amino acids were identified by ClustalW
alignment of human Bax alpha and its orthologs of Xenopus laevis and
Danio rerio and were highlighted in the published NMR structure of
human Bax alpha (Suzuki et al. 2000). Amino acids identical in all
sequences are shown in red. Substitutions which were classified as
highly conserved residues are marked in orange and semi-conserved
ones are displayed in yellow. d Demonstrates the hydrophobicity of
the surface exposed amino acids (according to the hydropathy index
by Kyte and Doolittle 1982). Acidic [E,D] and basic [K,R] amino
acids are shown in red and blue, respectively. Hydrophobic amino
acids [I,V,L,A,C,F,M] are shown in green and slightly hydrophobic
residues [G,T,S,W] in light green. Others [Q,N,P,H,Y] are marked in
grey. b–d Show two views of the molecule tilted by 180°
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(which is replaced by arginine in the zebra fish sequence),
are conserved (see Fig. 2). We recorded TF in order to
analyze the influence of detergents or membrane insertion
on the local environment of the tryptophan residues during
oligomerization.
The emission maximum of monomeric Bax was deter-
mined at 336 nm (Fig. 4b) showing the tryptophans in an at
least partially solvent accessible position (Royer 2006). This
is in line with the NMR structure (Suzuki et al. 2000) where
all tryptophanes are at least partially solvent exposed. The
oligomerization of Bax in detergent or liposomes caused a
blue shift of the TF emission maximum up to 9 nm (shown
in Fig. 4b emission maximum in DDM: 328 nm, in DM:
328 nm, in OG: 331 nm, in liposomes of bovine heart lipid
extracts: 327 nm). Additionally, the intensity of the TF
increased upon oligomerization (three- to fourfold for DM
and DDM, twofold for OG, not measured for Bax
reconstituted in liposomes; see Fig. 4c).
In order to understand the influence of detergents on the
TF emission independent of the influence of the detergents
on the protein, the emission spectrum of acetylated
tryptophan was recorded. The addition of detergent caused
nearly no shift in emission (data not shown), demonstrating
that all blue shifts shown were due to conformational
changes in the protein backbone and not to polarity shifts of
the buffer environment.
Protease treatment of heterologously expressed Bax and
Bax in mammalian cell extracts The increased hydropho-
bicity of the C-terminal part of Bax upon oligomerization
impliesthatpartsoftheproteinmaybecomeburiedinthecore
of the oligomer and might, therefore, be inaccessible for
proteases. Goping et al. (Goping et al. 1998)p e r f o r m e d
proteinase K digestion of Bax in mammalian cell extracts of
FL5.12 cells before and after induction of apoptosis (by
growth factor IL-3 withdrawal). The authors observed that
upon initiation of apoptosis and Bax activation the accessi-
bility of Bax to proteinase K changed. Their data indicate,
that proteinase K treatment caused an N-terminal truncation
of the activated Bax in natural membranes of apoptotic cells
whereas the N-terminus remained unchanged in the mono-
meric protein in untreated cells. In contrast, the monomeric
protein was cleaved at the C-terminus.
We repeated the protease treatment with heterologously
produced Bax to analyze, first, if the recombinant mono-
meric Bax and the detergent induced Bax oligomers adopt
conformations comparable to those of inactive, monomeric
and active, oligomeric Bax in mammalian cells, respective-
ly. Second, we intended to analyze the cleavage sites in
both conformations in order to understand the conforma-
tional change and further explore the conformation of the
oligomeric form.
On SDS gels, the band pattern after proteinase K or
subtilisin treatment of the heterologously produced mono-
Fig. 2 Amino acid sequence alignment of orthologous Bax alpha
representatives from mammals and vertebrates. Amino acids identical
in all sequences are colored in red and labeled with asterisks.
Substitutions of highly conserved residues are marked in orange
with colons and of semi-conserved residues are displayed in yellow
indicated with periods. The secondary structure (for color code see
Fig. 1a) as well as the position of the BH domains of Bax are also
shown
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mammalian cell extracts before and after induction of
apoptosis, respectively (Goping et al. 1998) (see Fig. 5a and
Western blots in Goping et al. 1998). Moreover, mass
analysis of the digested proteins revealed that the detergent
induced oligomer was truncated at the N-terminus, whereas
the monomeric form was cleaved at the C-terminus and its
N-terminus remained intact. Both observations are in line
with the data of Goping et al. (see Table 1 and Fig. 5b).
Further analysis of subtilisin (Fig. 5a) or proteinase K
(Fig. 7a and Table 1) treated monomeric Bax identified a
fragment lacking 16 C-terminal residues as the major
cleavage product. This was accompanied by fragments of
lower abundance lacking 18, 19 and 21 C-terminal
residues. Thus, the C-terminal helix α9 was protease
digested in the monomeric form suggesting that it is not
tightly attached to the protein, whereas the N-terminus was
quite stable (see Table 1).
By contrast, the detergent induced oligomers showed no
proteolytic cleavage at the C-terminus. However, the N-
terminal part of the protein was cleaved after Ser4, Met38,
Leu45, and, though less frequent, after Ala81 and Ala82 (see
Fig. 5b). The cut at Ser4 demonstrates that a cleavage within
the first 12 N-terminal amino acids, that were described to be
very flexible (Suzuki et al. 2000), is possible only in
oligomeric Bax, but the same domain is inaccessible in the
monomeric protein. It also showed that Bax oligomerization
provokes remarkable differences in the C- and N-terminus of
the protein, which is in agreement with the TF data and
previously reported observation (Roucou and Martinou 2001
and references therein). Briefly, we observed that oligomer-
ization led to exposure of N-terminal parts of Bax, especially
the loop between α1a n dα2 that contains Met38 and Leu45,
whereas α9 was protected from protease attack and must be
in a shielded environment likely to be located in the core
structure of the oligomer.
Since we were unable to do mass spectrometry analysis
with Bax inserted in liposomes (see Material and Methods),
proteolytic degradation of Bax liposomes was more
difficult to follow. However, N-terminal sequencing clearly
identified a Bax fragment lacking 38 N-terminal residues
after treatment with proteinase K. Since cleavage after
Fig. 3 Purification, folding and oligomerization of the Bax protein.
The SDS gel shown in a demonstrates the purity of Bax: (1) after the
chitin affinity chromatography (first purification step) (2) after anion
exchange chromatography (second purification step). Molecular
weight standard bands are indicated on the left margin. The calculated
molecular weight of Bax is 21 kD. b CD spectra of monomeric (black)
and oligomeric Bax in 0.5% DDM (red). c SEC analysis of
monomeric and oligomeric Bax as well as monomeric Bax pre-
incubated at 90 °C. Monomeric Bax is shown in black and eluted as a
monomer with a small amount of dimers. Oligomeric Bax (in 0.5%
DDM) is shown in red and monomeric Bax pre-incubated at 90 °C in
purple. The arrows mark the exclusion volume as well as the elution
maxima of ferritin (440 kD) and chymotrysiongen A (25 kD)
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the Bax conformations in both membrane mimicking
environments seems not to vary much.
Monomeric Bax is more temperature sensitive than oligomeric
Bax. Yethon et al. (2003) reported differences in the
melting behavior of monomeric Bax and Bax inserted in
liposomes (DOPC: DOPE: DOPS: PI: CL, 43: 27: 9: 9: 12
molar ratio). They showed, that monomeric Bax is very
resistant to temperature depending denaturation and heat
stability even increases in the presence of lipids. However,
it remains unclear which part of the protein unfolds during
heat treatment and if detergent has a similar stabilizing
effect as liposomes.
In order to test the heat stability of oligomeric Bax in
detergent, we recorded melting curves of the protein. The
curves of monomeric Bax looked comparable to those of
Yethon et al. (2003). Moreover, the stability of Bax in
detergent and in liposomes seems to be similar, as far as
both increase stability a lot compared to the monomeric
form (see melting curves in Fig. 6 upper and lower panel
and Yethon et al. 2003).
Monomeric Bax showed a sigmoidal melting curve and
started to unfold at temperatures higher than 75 °C. But
even at 90 °C melting was not completed (shown in Fig. 6
lower panel) and a CD-spectrum at 90 °C revealed still α-
helical line shape with a remaining α-helical content of
35% (see Fig. 6 upper panel). Subsequent cooling to 4 °C
resulted in a renaturation of 45% α-helices (see Fig. 6
upper panel). Addition of detergent (DDM) at 90 °C or after
heating caused a better but still only partly refolding of the
helices (up to 50% α -helices, data not shown).
In order to identify partially unfolded sub-structures
of monomeric Bax at increased temperatures, the protein
w a ss l o w l yw a r m e dt o5 0° C ,6 0° C ,7 0° C ,8 0° Co r
90 °C, followed by a rapid cooling to 4 °C and
digestion using proteinase K (proteolytic fragments
Fig. 5 AnalysisofsubtilisintreatedBax.Fragmentsofdifferentlytreated
Bax samples after proteolysis with subtilisin are shown on a coomassie-
stained 17% SDS gel in a. Untreated monomeric Bax was loaded onto
lane 1, subtilisin treated monomeric Bax is shown in lane 2, oligomeric
Bax (in 0.5% DDM) after proteolysis with subtilisin refers to lane 3.
Monomeric and oligomeric (in 0.5% DM) Bax both pre-heated to 90 °C
are presented in lane 4 and lane 5, respectively. Subsequent analysis of
proteolytic products after heating revealed different fragments of Bax,
which are labeled with asterisks for full length Bax (aa 1–192 and aa 1–
191), number sign for aa 1–176, aa 1–174 and aa 1–173, degree symbol
for aa 39–192, aa 47–192, aa 39–191 and aa 47–191, plus symbol aa
82–192 and aa 83–192 as well as section symbol for aa 1–39 and aa1–
46. In b the main cleavage sites in monomeric (black) and oligomeric
(red)B a xa r eh i g h l i g h t e db yarrows
Fig. 4 Tryptophan fluorescence of Bax. The positions of the
tryptophans in the secondary structure of Bax are highlighted by
arrows and corresponding labels in a. The color code is the same as
described for Fig. 1a. TF spectra (normalized to 1) of monomeric and
oligomeric Bax in different detergents as well as Bax reconstituted in
liposomes are shown in b. Not Normalized TF spectra are shown in c
with the same color code as indicated in b
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did not change. After heating to 80 °C, a mixture of N-
terminal (cleaved after Ala46) and C-terminal truncated
Bax (mainly cleaved after Phe176) was identified. Pre-
incubation at 90 °C led to a completely inaccessible C-
terminus, but cleavage of the 45 N-terminal amino acids
(see Fig. 7a and Table 1). In summary the experiment
showed that the N-terminus of monomeric Bax became
accessible and therefore is likely to be unfolded after heat
treatment, whereas the rest of the molecule seems to be
stable. Additionally, the cleavage pattern of monomeric
heat treated Bax is similar to the one monitored with
untreated oligomeric Bax (see Fig. 7a).
Detailed analysis of Bax incubated at 90 °C prior to
proteolysis showed that the protein is not monomeric
anymore, but forms aggregates or very big oligomers
(furthermore called “megaoligomers”) that are larger than
normal detergent or liposome-induced oligomers. Mega-
oligomers were identified by SEC (Fig. 3c) and cross-link
analysis (Fig. 7b). However, they are too small to scatter
light at 215 nm arguing against protein aggregation.
After cross-linking of oligomeric Bax (in DDM) and
subsequent analysis on SDS-gels big oligomers appeared
(up to octamers, as shown in Fig. 7b; varying the conditions
pointed to even bigger oligomers). Noticeable most
oligomers were even numbered (see Fig. 7b). Surprisingly,
proteinase K digestion, gel electrophoresis and cross-
linking of oligomeric Bax that was pre-incubated at 90 °C
showed no differences as to when kept at 4 °C (shown in
Fig. 7a, b). From these observations we concluded that Bax
oligomers resist temperatures up to 90 °C.
Comparison of both Bax conformations in chaotrophic
reagents After recognition of the unusual Bax stability even
at elevated temperatures, we were curious to see whether the
protein was also resistant towards chemical denaturation.
Therefore, the protein was mixed with increasing concen-
trations of chaotropic reagents. We recorded TF emission
spectra to detect the reagent concentration at which denatur-
ation of the protein takes place. Surprisingly, no shift in the
emission maxima of either monomeric or oligomeric Bax
could be observed in 8 M urea (illustrated in Fig. 8a). At a
concentration of 4.5 M guanidinium hydrochloride denatur-
ation of monomeric Bax was induced and at 6 M guanidi-
nium hydrochloride the emission maximum was shifted to
346 nm (see Fig. 8b) indicating protein unfolding. Thus,
monomeric Bax showed a very high stability towards
chemical denaturation. This behavior was even more
pronounced in oligomeric Bax. At 6 M guanidinium
hydrochloride the emission maximum of oligomeric Bax in
0.5% DDM was only slightly shifted (4 nm) to 332 nm (see
Fig. 8b), indicating a folded protein.
Discussion
Bax is involved in the intrinsic apoptotic pathway and
known to exist in two distinct structural conformations:
inactive Bax is monomeric, whereas the active protein
Fig. 6 Melting behavior of heat treated monomeric and oligomeric
Bax. The thermal stability of monomeric (black) and oligomeric (red)
Bax is shown. The upper panel depicts the decrease of the alpha
helical content of Bax during the temperature increase, estimated from
CD spectra taken at different temperatures. The alpha helical content
of Bax heated to 90 °C and recooled to 4 °C is highlighted by arrows.
The lower inset panel indicates the decrease of the ellipticity at
222 nm measured during the whole temperature increase
Table 1 Proteinase K cleavage fragments of Bax
Identified
proteolytic
fragments
4°C 90°C
Monomer Oligomer
(detergent)
Monomer Oligomer
(detergent)
aa 1–192 <30% <40% ––
aa 1–38 Traces –
aa 1–46
aa 1–176 >50%
aa 1–174 <20% –– –
aa 1–172
aa 1–171
aa 39–192 <10% >50% >80% >80%
aa 47–192 –
aa 39–176 Traces
aa 82–192
82–191
83–191
83–192
85–192
85–191
– <10% <10% <10%
aa 53–192, aa
58–192
–– <10% <10%
Amounts of fragments identified by mass analysis of monomeric and
oligomeric Bax after proteinase K digestion with and without pre-
incubation of Bax at 90 °C; aa amino acid.
36 J Bioenerg Biomembr (2009) 41:29–40forms an oligomer. In vivo it is activated by apoptotic
stimuli and, thus, decides on the death or survival of a cell
(Kuwana and Newmeyer 2003). During its activation Bax
inserts into the MOM and forms a pore by oligomerization
(Antonsson et al. 2001; Kuwana et al. 2002; Nechushtan et
al. 2001). Through this pore cytochrome c is released
promoting further apoptotic events (reviewed in Antignani
and Youle 2006; Kuwana and Newmeyer 2003; Reed 2006
and references therein). Activation of Bax is known to
involve conformational rearrangements such as the inser-
tion of the helices α5, α6 and α9 into the MOM (Annis et
al. 2005).
We address two main questions in this work: First, we
intended to identify which part(s) of Bax are involved in
structural rearrangements during oligomerization. Further-
more, it was important to assess whether the recombinantly
produced monomeric Bax and the detergent induced Bax
oligomer folded in the same way as does Bax in non-
apoptotic and apoptotic mammalian cells, respectively.
Since structural data on Bax conformation in living cells
are difficult to obtain and, therefore, are limited we decided
to focus on in vitro studies. Detergent induced oligomeri-
zation of Bax has previously been used to study conforma-
tional rearrangements of Bax (Antonsson et al. 2000; Hsu
and Youle 1997). However, these studies did not convinc-
ingly reveal that the fold of detergent oligomerized Bax
corresponds to that in apoptotic cells. In order to better
mimic the natural environment of Bax we also reconstituted
the protein into liposomes.
SEC and secondary structure analysis showed that the
recombinantly produced Bax was monomeric and folded as
previously reported in the literature (Suzuki et al. 2000;
Yethon et al. 2003). Detergent induced Bax oligomerization
was confirmed by SEC and chemical cross-linking (refer to
Fig. 3ca n dF i g .7b). The conformation of liposome
reconstituted Bax was not accessible by SEC, however,
chemical cross-linking yielded mainly dimers (shown in
Fig. 7c). Our inability to detect higher number Bax
oligomers in liposomes may be explained by the chemical
cross-linker’s charge which renders it unlikely to move freely
in the hydrophobic lipid environment. It appears that
possible other oligomerization sites were buried within the
lipid matrix and were, thus, inaccessible to the cross-linker.
The secondary structures of monomeric and detergent
solubilized Bax were similar and showed an alpha helical
content of about 60–65% (CD-spectroscopy data shown in
Fig. 7 Properties of heat treated Bax. Monomeric and oligomeric
Bax were incubated at different temperatures for 10 min, cooled
on ice and treated with proteinase K for 1 h on ice (a)o rc r o s s
linked (b). Cross link oligomers in liposomes are shown in c.
Separation was done on 4–12% gradient SDS gels and analyzed. a
Untreated monomeric Bax was loaded onto lane 1,p r o t e i n a s eK
treated monomeric Bax pre-incubated at different temperatures were
loaded onto lanes 2 through 7: lane 2 4° C ,lane 3 50 °C, lane 4 60 °C,
lane 5 70 °C, lane 6 80 °C and lane 7 90 °C. In lane 8 and 9 oligomeric
Bax (in 0.5% DM) was pre-incubated at different temperatures: lane
8 4 °C, lane 9 90 °C. Mass analysis of the proteolytic products after
pre-heating revealed differently sized Bax fragments. The labeling is
equal to that shown in Fig. 5a. b Monomeric and oligomeric Bax
proteins cross-linked after pre-incubation at different temperatures:
Lane 1 untreated monomeric Bax pre-incubated at 4 °C, lane 2 to 6:
monomeric Bax after pre-incubation at different temperatures and
cross-linking for 5 s: lane 2 4 °C, lane 3 50 °C, lane 4 70 °C, lane 5
80 °C, lane 6 90 °C, lane 7 monomeric Bax pre-incubated at 90 °C
without cross-linking, lane 8 untreated oligomeric Bax (0.5% DDM)
pre-incubated at 4 °C, lane 9–13 oligomeric Bax (0.5% DDM) pre-
incubated at different temperatures and after cross-linking for 5 s, lane
9 4 °C, lane 10 50 °C, lane 11 70 °C, lane 12 80 °C, lane 13 90 °C,
lane 14 oligomeric Bax (0.5% DDM) pre-incubated at 90 °C without
cross-linking. The main visible band and the number of cross linked
monomers per band are indicated by arrows and numbers on the right
margin. The asterisk indicates aggregates or big oligomers that did not
enter the gel. c Demonstration of a silver stained SDS-gel of
reconstituted Bax oligomers (without heat treatment) before and after
cross-linking. The arrows indicates monomers and dimers. The bands
framed by the black box are not protein but lipid bands

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meric and liposome reconstituted Bax also contained
approximately 65% alpha helix (Suzuki et al. 2000; Yethon
et al. 2003).
In order to identify structurally important regions in Bax
we initiated our studies with an in silico analysis. The
alignment of Bax amino acid sequences from different
vertebrate species revealed a highly conserved C-terminal
halfoftheproteinswhereastheN-terminalhalfwithexception
ofhelixα2islessconserved(seeFig.2). This implies that the
C-terminus of the Bax proteins is more likely involved in
Bax function than the N-terminal half (except α2). By
projecting the conserved amino acids onto the NMR
structure of Bax (Suzuki et al. 2000) a hydrophobic region
on the protein surface which is composed of α2( B H 3 ) ,t h e
loop between α4a n dα5, a part of α5 (BH1) as well as the
region of α7t oα9 (containing BH2) became evident (see
Fig. 1). The high conservation and the accumulation of BH
domains within this region implicate an important role in
Bax function. For Bax to act as a cytochrome c pore the
protein must run through a series of distinct events: (1)
activation by an appropriate trigger, followed by (2) its
membrane insertion and (3) either subsequent or simulta-
neous oligomerization. It appears conceivable that the highly
conserved surface region is relevant for at least one of the
above outlined events.
Interestingly, five of six tryptophans in the Bax sequence
are present in the highly conserved surface region (all
except Trp139). TF spectroscopy revealed alterations in the
environment of the tryptophans upon Bax oligomerization
in both, detergent and liposomes. Dependent on the
detergent or the lipids, the hydrophobicity of the tryptophan
environment increased as indicated by an up to 9 nm blue
shift of the TF emission maximum (see Fig. 4b). Moreover,
the concomitant increase in fluorescence intensity suggests
a diminished accessibility of the tryptophan residues to
oxygen (Fig. 4c). Consequently, at least some of the
tryptophans are shielded from oxygen which quenches TF.
Oxygen concentrations are usually higher in lipid bilayers
and in aqueous solution than in the protein core (Altenbach
et al. 1994; Dzikovski et al. 2003; Marsh et al. 2006)).
Thus, our observations strongly support the notion that at
least some of the tryptophan residues take part in the
formation of the core oligomeric structure. This idea was
also confirmed by the results of the proteinase K digestions
discussed below.
The changes in TF emission wavelength and intensity
upon Bax oligomerization varied between different deter-
gents and liposomes (see Fig. 4b, c). Whereas the TF of
oligomeric Bax in DDM, DM and liposomes was compa-
rable, Bax oligomerization in OG showed a smaller blue
shift and a lower increase in TF intensity. This might be due
to the smaller alkyl chain and possibly the differ in micellar
shape of OG in contrast to the other detergents and the
lipids, causing a less effective protection of the hydropho-
bic parts of the protein (Lipfert et al. 2007).
As mentioned before protease digestion experiments
indicated changes in the conserved surface region upon
oligomerization. NMR data suggest that in monomeric Bax,
α9 is buried in a hydrophobic cleft on the protein surface
(Suzuki et al. 2000). In this study, we found that α9i s
subject to proteinase K and subtilisin degradation (see
Fig. 5) and, thus, must be at least temporarily solvent
exposed. In contrast, α9 was not degraded in the oligomeric
protein (see Fig. 5). α9 is a very hydrophobic helix and its
movement away from the protein surface could enable its
insertion into the lipid membrane. Thus, helix α9 may
function as a membrane sensor and, subsequently, mem-
brane anchor that promotes Bax activation (also proposed
by Nechushtan et al. 1999).
In summary, our data obtained by TF and protease
digestion suggest that at least a part of the conserved Bax
Fig. 8 TF of monomeric and oligomeric Bax after treatment with denaturing agents. Treatment with urea is shown in a and treatment with
guanidinium hydrochloride in b. The data were normalized and maximal TF emission was set to 1
38 J Bioenerg Biomembr (2009) 41:29–40surface regionchanges its conformationuponoligomerization
and is likely to form the core of the oligomeric protein. This is
in line with the data of others who showed that α5a n dα9( a s
wellas α6, which was not included in the regioninvestigated)
become membrane inserted upon Bax activation (Annis et al.
2005; Garcia-Saez et al. 2005; Garcia-Saez et al. 2006).
In order to figure out whether our proteinase K cleavage
patterns of Bax mirror the situation in vivo or are merely in
vitro artifacts, we compared them to proteinase K digestion
patterns Goping et al. obtained of Bax in mammalian cell
extracts before and after induction of apoptosis (Goping et
al. 1998). We were able to show that recombinantly
produced monomeric and detergent induced oligomeric
Bax had similar cleavage patterns as Bax in cells before and
after apoptosis induction, respectively (see Fig. 5 and
Goping et al. 1998). This finding indicates a comparable
fold of the recombinantly produced Bax and Bax in
mammalian cells.
The less conserved N-proximal part of Bax before α2( s e e
Fig. 2) most noticeably changed its conformation and
became solvent exposed upon oligomerization. This region
was cleaved by proteinase K and subtilisin from oligomeric
Bax in detergent and liposomes but only to a minor extent
from the monomeric form (see Fig. 5). The same region was
unfolded during heat treatment, which will be discussed later.
Cartron et al. (2003) showed that α1 is important in
membrane binding but not membrane insertion (Cartron
et al. 2003). α1 deletion (Bax Δ1-37) inhibits membrane
insertion of Bax (Cartron et al. 2003) and the mutant protein
is unable to fold into the active conformation. Additionally,
it is unclear whether it can adopt the normal monomeric
conformation. C-terminal to α1 a long (15 amino acids),
flexible (shown by NMR (Suzuki et al. 2000)) loop is found
in all solved animal Bcl-2 structures. The loop seems to
have a regulatory function (reviewed in (Petros et al. 2004)
and references therein). In our studies, proteinase K and
subtilisin cleaved oligomeric Bax mainly in this loop (see
Fig. 5b and Table 1). In vivo Bax is cleaved in this loop by
calpain, which leads to increased apoptosis (Altznauer et al.
2004; Gao and Dou 2000). Taking all findings together, α1
seems crucial for Bax to adopt its correct monomeric
conformation, but as soon as folding is completed α1 can
be removed, thereby enhancing Bax activation.
From the literature it is known that monomeric and
oligomeric Bax are very heat stable (Yethon et al. 2003),
and that heating to 43 °C activates Bax in mammalian cell
extracts (Pagliari et al. 2005). The latter indicates that the
conformational change of Bax is facilitated by heat in the
presence of membranes. The melting curves we obtained
for monomeric and detergent induced oligomeric Bax were
very similar to those recorded by Yethon et al. on
monomeric Bax and Bax inserted in liposomes (see Fig. 6
and (Yethon et al. 2003)). Bax resisted thermal denaturation
in both conformations: The monomer contained 35%
residual α-helices at 90 °C (sigmoidal curve shape; see
Fig. 6) while the oligomer was even less affected by heat
(residual α-helical content >40%, non-sigmoidal curve
shape; Fig. 6). This observation raised a couple of new
questions: Which parts of the monomeric protein were the
most stable ones? Can we identify differences in the protein
structure before and after heat treatment? Can the protein
also resist chemical unfolding? And why is a protein of a
mesophilic, endothermic organism so stable against heat?
Detergent oligomerized Bax showed a melting curve
comparable to that observed by Yethon et al. (2003)w i t h
Bax reconstituted in lipids. The refolding efficiency surpassed
theirs(Yethonetal.2003) and complete refolding occurred at
lower temperatures. Similar to Yethon et al. (2003), we found
that monomeric Bax irreversibly unfolded upon heating.
After heating to at least 70 °C and subsequent cooling to
4 °C (heat treatment), monomeric Bax showed an aberrant
fold, distinct from the normal monomeric or oligomeric
Bax conformations. Instead, “monomeric” Bax formed a
“megaoligomer” which was never obtained after heat
treatment of the oligomeric form (shown in Fig. 7b). In
the Bax megaoligomer, the N-terminus preceding α2b e c a m e
accessible to proteases; whereas α9 at the C-terminus
becameinaccessible. This resembles the proteaseaccessibility
of the oligomeric Bax (see Table 1). Normal Bax oligomers
are only formed in the presence of detergents or liposomes.
We assume that in the absence of solubilizing molecules,
hydrophobic patches emerging at high temperatures due to
partial denaturation of the protein cannot be shielded. Hence,
upon cooling the hydrophobic parts of the Bax molecules
avoid exposure to the hydrophilic environment by assembly
into megaoligomers. The hydrophobic α9 (see Fig. 1d) may
form part of these patches.
On the contrary, the better secondary structure recovery of
Bax in detergents as compared to Bax in liposomes after heat
treatment might be due to the lower size and the higher
flexibility of the detergent micelles. Although CD spectros-
copydoesnotprovidedirectevidence,liposomesareexpected
tobedestroyedatelevatedtemperatureswhereasthedetergent
molecules maintain their solubilizing function. The shape of
the melting curve indicated partial unfolding of the detergent
induced Bax oligomers. Nevertheless, a part of the oligomer
(maybe to hydrophobic core) seems to remain stable allowing
complete refolding of the oligomer during cooling with the
detergent molecules shielding the hydrophobic patches.
Pagliari et al. (2005)a l s os h o w e db yc r o s sl i n k i n go l i g o m e r
assembly after heating Bax monomers lacking α9t o4 3° C .
This shows that without α9 Bax resistance against heat
seemed to be weakened.
Bax is not only very heat stable but revealed a high
resistance against chemical denaturation as well. Again, the
monomeric form was affected (see Fig. 8) whereas the
J Bioenerg Biomembr (2009) 41:29–40 39oligomer was almost completely stable under all tested
conditions. These findings raised the question why a human
protein would exhibit such a high stability rarely known
from other human proteins. Cancer or virus infected cells
seek to suppress apoptosis. Bax represents an ideal target for
apoptosis suppression, but its high stability might put up the
necessary resistance.
In summary, we showed that Bax is a very indestructible
protein, although substantial conformational changes occur
during its activation. On the one hand, we detected significant
changes in the region preceding α2. Here, α1 seems to have
an important function in adopting the monomeric conforma-
tion, but loses importance as soon as the folding is complete.
Inlivingcells itiscut bycalpain leadingtoBaxactivation.On
the other hand, a highly conserved, hydrophobic surface
region composed of α2, the loop between α4a n dα5, parts of
α5, and α7t oα9 and, therefore, significant parts of all three
BH domains of Bax seem to be important for and involved in
the conformational change. Upon oligomerization this region
is exposed to a more hydrophobic environment and α9
becomes inaccessible for proteases. In order to understand the
oligomeric structure of Bax in more detail, we are currently
performing further analyses on the structural properties of the
protein in the monomeric as well as oligomeric form.
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